Detalhe da pesquisa
1.
Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer.
Cell
; 184(2): 384-403.e21, 2021 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33450205
2.
Inhibition of YTHDF2 triggers proteotoxic cell death in MYC-driven breast cancer.
Mol Cell
; 81(15): 3048-3064.e9, 2021 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34216543
3.
The spliceosome is a therapeutic vulnerability in MYC-driven cancer.
Nature
; 525(7569): 384-8, 2015 Sep 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-26331541
4.
Erratum: iTAG an optimized IMiD-induced degron for targeted protein degradation in human and murine cells.
iScience
; 27(5): 109727, 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38646177
5.
DNMT3A-coordinated splicing governs the stem state switch towards differentiation in embryonic and haematopoietic stem cells.
Nat Cell Biol
; 25(4): 528-539, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37024683
6.
iTAG an optimized IMiD-induced degron for targeted protein degradation in human and murine cells.
iScience
; 26(7): 107059, 2023 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37360684
7.
Energy-stress-mediated AMPK activation inhibits ferroptosis.
Nat Cell Biol
; 22(2): 225-234, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32029897
8.
Tumor progression and chromatin landscape of lung cancer are regulated by the lineage factor GATA6.
Oncogene
; 39(18): 3726-3737, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32157212
9.
Upholding routine hour blood collections against the night-shift timings.
Transfus Clin Biol
; 30(2): 185-187, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36496164
10.
Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancer.
Nat Med
; 24(4): 505-511, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29578538
11.
The oncogenic STP axis promotes triple-negative breast cancer via degradation of the REST tumor suppressor.
Cell Rep
; 9(4): 1318-32, 2014 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25453754